Ghavamzadeh A - Search Results

1

Prognostic factors in bone marrow transplantation for beta thalassemia major: experiences from Iran.

Ghavamzadeh A, Nasseri P, Eshraghian MR, Jahani M, Baybordi I, Nateghi J, Khodabandeh A, Sadjadi AR, Mohyeddin M, Khademi Y. Ghavamzadeh A, et al. Bone Marrow Transplant. 1998 Dec;22(12):1167-9. doi: 10.1038/sj.bmt.1701509. Bone Marrow Transplant. 1998. PMID: 9894719

2

Bone marrow transplantation in Iran.

Ghavamzadeh A, Jahani M, Baybordi E. Ghavamzadeh A, et al. Bone Marrow Transplant. 1994 Jun;13(6):743-4. Bone Marrow Transplant. 1994. PMID: 7920308

3

Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation.

Ghavamzadeh A, Alimoghadam K, Nasseri P, Jahani M, Khodabandeh A, Ghahremani G. Ghavamzadeh A, et al. Bone Marrow Transplant. 1999 Feb;23(3):299-301. doi: 10.1038/sj.bmt.1701567. Bone Marrow Transplant. 1999. PMID: 10084264

4

Esophageal cancer in Iran.

Ghavamzadeh A, Moussavi A, Jahani M, Rastegarpanah M, Iravani M. Ghavamzadeh A, et al. Semin Oncol. 2001 Apr;28(2):153-7. doi: 10.1016/s0093-7754(01)90086-7. Semin Oncol. 2001. PMID: 11301377 Review.

5

Effect on growth parameters of bone marrow transplantation with a chemotherapy-only conditioning regimen.

Khoshniat M, Ghavamzadeh A, Larijani B, Bahar B, Tabatabaei O. Khoshniat M, et al. Among authors: ghavamzadeh a. Transplant Proc. 2003 Dec;35(8):3085-8. doi: 10.1016/j.transproceed.2003.10.031. Transplant Proc. 2003. PMID: 14697985

6

Thyroid, parathyroid, gonadal, and pancreatic beta-cell function after bone marrow transplantation with chemotherapy-only conditioning.

Ghavamzadeh A, Larijani B, Jahani M, Khoshniat M, Bahar B, Tabatabaei O. Ghavamzadeh A, et al. Transplant Proc. 2003 Dec;35(8):3101-4. doi: 10.1016/j.transproceed.2003.10.030. Transplant Proc. 2003. PMID: 14697989

7

Are HLA antigens a risk factor for acute GVHD in thalassemic patients receiving HLA-identical stem cell transplantation?

Mohyeddin Bonab M, Alimoghaddam K, Vatandoust S, Forouzia F, Jahani M, Ghavamzadeh A. Mohyeddin Bonab M, et al. Among authors: ghavamzadeh a. Transplant Proc. 2004 Dec;36(10):3190-3. doi: 10.1016/j.transproceed.2004.10.088. Transplant Proc. 2004. PMID: 15686726

8

Cyclosporin A and mini short-term methotrexate vs cyclosporin A as graft-versus-host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantation.

Iravani M, Mousavi A, Gholibeikian S, Bahar B, Samiee S, Ashouri A, Eghbal L, Ghavamzadeh A. Iravani M, et al. Among authors: ghavamzadeh a. Bone Marrow Transplant. 2005 Jun;35(11):1095-9. doi: 10.1038/sj.bmt.1704935. Bone Marrow Transplant. 2005. PMID: 15821773

9

Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy.

Ghavamzadeh A, Alimoghaddam K, Ghaffari SH, Rostami S, Jahani M, Hosseini R, Mossavi A, Baybordi E, Khodabadeh A, Iravani M, Bahar B, Mortazavi Y, Totonchi M, Aghdami N. Ghavamzadeh A, et al. Ann Oncol. 2006 Jan;17(1):131-4. doi: 10.1093/annonc/mdj019. Epub 2005 Oct 14. Ann Oncol. 2006. PMID: 16227315 Free article.

10

Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients.

Iravani M, Evazi MR, Mousavi SA, Shamshiri AR, Tavakoli M, Ashouri A, Samiee S, Chahardovali B, Alimoghaddam K, Ghaffari SH, Ghavamzadeh A. Iravani M, et al. Among authors: ghavamzadeh a. Bone Marrow Transplant. 2007 Jul;40(2):105-10. doi: 10.1038/sj.bmt.1705685. Epub 2007 Apr 30. Bone Marrow Transplant. 2007. PMID: 17468775

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters